Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Plasma level monitoring of the major metabolites of diacetylmorphine (heroin) by the "chasing the dragon" route in severe heroin addicts.

Dubois N, Demaret I, Ansseau M, Rozet E, Hubert P, Charlier C.

Acta Clin Belg. 2013 Sep-Oct;68(5):359-67.

PMID:
24579243
2.

[Efficacy diacetylmorphine (pharmaceutical heroin) for heroin treatment ].

Demaret I, Lemaître A, Ansseau M.

Rev Med Liege. 2010 Dec;65(12):681-7. French.

PMID:
21287763
4.

Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.

Bravo MJ, Llorens N, Barrio G, Brugal MT, Santos S, Sordo L, de la Fuente L; Itinere Project Group.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):62-8. doi: 10.1016/j.drugalcdep.2010.05.014. Epub 2010 Jun 29.

PMID:
20591582
5.

Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients.

Walter M, Wiesbeck GA, Degen B, Albrich J, Oppel M, Schulz A, Schächinger H, Dürsteler-MacFarland KM.

Addict Biol. 2011 Jan;16(1):145-51. doi: 10.1111/j.1369-1600.2010.00205.x.

PMID:
20331562
6.

Screening for illicit heroin use in patients in a heroin-assisted treatment program.

Rook EJ, Huitema AD, van den Brink W, Hillebrand MJ, van Ree JM, Beijnen JH.

J Anal Toxicol. 2006 Jul-Aug;30(6):390-4.

7.

Diacetylmorphine versus methadone for the treatment of opioid addiction.

Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT.

N Engl J Med. 2009 Aug 20;361(8):777-86. doi: 10.1056/NEJMoa0810635.

8.

Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program.

Klous MG, Rook EJ, Hillebrand MJ, van den Brink W, van Ree JM, Beijnen JH.

J Anal Toxicol. 2005 Sep;29(6):564-9.

9.

Controlled trial of prescribed heroin in the treatment of opioid addiction.

March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F; PEPSA team.

J Subst Abuse Treat. 2006 Sep;31(2):203-11. Epub 2006 Jul 18.

PMID:
16919749
10.

Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics.

Rentsch KM, Kullak-Ublick GA, Reichel C, Meier PJ, Fattinger K.

Clin Pharmacol Ther. 2001 Sep;70(3):237-46.

PMID:
11557911
11.

Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: a comparison of three models.

Yan L, Liu E, McGoogan JM, Duan S, Wu LT, Comulada S, Wu Z.

BMC Public Health. 2013 Aug 13;13:747. doi: 10.1186/1471-2458-13-747.

12.

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.

Strang J, Metrebian N, Lintzeris N, Potts L, Carnwath T, Mayet S, Williams H, Zador D, Evers R, Groshkova T, Charles V, Martin A, Forzisi L.

Lancet. 2010 May 29;375(9729):1885-95. doi: 10.1016/S0140-6736(10)60349-2.

PMID:
20511018
13.

Efficacy of Heroin-assisted Treatment In Belgium: A Randomised Controlled Trial.

Demaret I, Quertemont E, Litran G, Magoga C, Deblire C, Dubois N, De Roubaix J, Charlier C, Lemaître A, Ansseau M.

Eur Addict Res. 2015;21(4):179-87. doi: 10.1159/000369337. Epub 2015 Apr 1.

PMID:
25832522
14.

Craving and illicit heroin use among patients in heroin-assisted treatment.

Blanken P, Hendriks VM, Koeter MW, van Ree JM, van den Brink W.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):74-80. doi: 10.1016/j.drugalcdep.2011.06.025. Epub 2011 Jul 22.

PMID:
21782351
15.

Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs.

Musshoff F, Trafkowski J, Lichtermann D, Madea B.

Int J Legal Med. 2010 Sep;124(5):499-503. doi: 10.1007/s00414-009-0361-8. Epub 2009 Aug 12.

PMID:
19672612
16.

Familial expressed emotion among heroin addicts in methadone maintenance treatment: does it matter?

Lee CH, Wang TJ, Tang HP, Liu YH, Bell J.

Addict Behav. 2015 Jun;45:39-44. doi: 10.1016/j.addbeh.2015.01.014. Epub 2015 Jan 21.

PMID:
25638535
17.
18.

Development and manufacture of diacetylmorphine/caffeine sachets for inhalation via 'chasing the dragon' by heroin addicts.

Klous MG, Nuijen B, van den Brink W, van Ree JM, Beijnen JH.

Drug Dev Ind Pharm. 2004 Aug;30(7):775-84.

PMID:
15491055
19.

Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.

Wang PW, Wu HC, Yen CN, Yeh YC, Chung KS, Chang HC, Yen CF.

Am J Drug Alcohol Abuse. 2012 May;38(3):213-9. doi: 10.3109/00952990.2011.649222. Epub 2012 Feb 22.

PMID:
22352836
20.

Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.

Cone EJ.

Forensic Sci Int. 2012 Feb 10;215(1-3):88-91. doi: 10.1016/j.forsciint.2011.01.046. Epub 2011 Mar 4.

PMID:
21377302
Items per page

Supplemental Content

Write to the Help Desk